Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:858-862

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dustan, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dustan, H. P.

(Hypertension. 1995;26:858-862.)
© 1995 American Heart Association, Inc.


Articles

Does Keloid Pathogenesis Hold the Key to Understanding Black/White Differences in Hypertension Severity?

Harriet P. Dustan, Principal Discussant

From the University of Vermont, College of Medicine, Burlington.

Correspondence to Harriet P. Dustan, 34 Lang Dr, Essex, VT 05452.

Abstract Repeated national surveys have shown that in the United States hypertension is more common and more severe in the black than in the white population. This discussion presents the hypothesis that the racial difference in hypertension severity is because of differences in growth factors (cytokines) affecting vascular smooth muscle cell growth. This hypothesis is derived from studies of keloids, which occur almost exclusively in blacks. Keloid fibroblasts in culture have growth characteristics that differ substantially from those of normal skin. Furthermore, there is evidence that peripheral blood mononuclear cells from patients with keloids produce different amounts of cytokines than do similar preparations from the blood of individuals without keloids. A growing body of evidence indicates that growth factors play a pivotal role in the pathogenesis of atherosclerosis, in experimental forms of hypertension, and in various renal diseases; it may be that they function in clinical hypertension as well.


Key Words: Blacks • keloid • muscle, smooth, vascular • cytokines




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. E. Tarver-Carr, N. R. Powe, M. S. Eberhardt, T. A. LaVeist, R. S. Kington, J. Coresh, and F. L. Brancati
Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States: A Population-Based Study of Potential Explanatory Factors
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2363 - 2370.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. D. Frohlich
Harriet Pearson Dustan
Hypertension, August 1, 1999; 34(2): 162 - 163.
[Full Text] [PDF]